Medical Weight Loss for Chester, Pennsylvania Residents
Chester, Pennsylvania residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Chester through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Chester Residents Choose New Hope Weight Loss
Since 2020, New Hope Weight Loss has treated more than 5,400 patients from its Costa Mesa, California clinic, and Chester, Pennsylvania residents get that same physician-led program by telehealth. Pricing is flat and transparent, with care overseen by Dr. Anjmun Sharma, M.D., and no insurance required to start.
Chester is served by telemedicine from our Costa Mesa, California clinic. The same physician-supervised semaglutide and tirzepatide programs are available by secure video, with medication shipped to your door.
For Chester, medical weight loss is delivered online from our Costa Mesa, California practice, with no travel required. We care for patients throughout downtown Chester and the greater Delaware County area of the Philadelphia metro. Every prescription for Chester is authorized by Dr. Sharma after reviewing your history, and follow-up continues by video throughout the program.
Whether you live in central Chester or its outskirts, you get exactly the same care and the same price. Compounded semaglutide and tirzepatide are not FDA-approved or brand-identical, which Dr. Sharma reviews with you before you begin.
GLP-1 Weight Loss Programs Available
Two GLP-1 programs for Chester
Compounded semaglutide starts at $166/month (a 90-day program is $499) and uses the same active ingredient as Wegovy® and Ozempic®, which produced 15-17% average body-weight loss in clinical trials. Compounded tirzepatide starts at $233/month · just $7.70/day and uses a dual GLP-1/GIP mechanism shown to reach up to 22.5% in trials.
Every plan begins with a $119 physician review. Medication is billed separately, and HSA, FSA, Klarna, and Affirm are all accepted, with no distance surcharge.
How Telehealth Works for Chester
1. Tell us your history through the quiz or intake form. 2. Dr. Sharma confirms your eligibility by secure video, usually within 48 hours. 3. Your compounded medication arrives at your Chester address in cold-pack packaging, with ongoing follow-up from the team, all without leaving home.
Frequently Asked Questions, Chester
How do I get treatment from Chester?
As a Chester, Pennsylvania patient you connect with our Costa Mesa, California clinic by telehealth. Dr. Sharma oversees your plan by secure video and compounded medication ships to your home; eligibility is confirmed during the consultation.
Can I do this without an in-person visit from Chester?
Yes, it is fully telehealth. Your review, prescription, and follow-up are remote, with medication shipped to Chester in cold-pack packaging, no lines and no drive.
How much does it cost for Chester patients?
A $119 physician review, then compounded semaglutide from $166/month or tirzepatide from $233/month (medication separate). HSA, FSA, Klarna, and Affirm are accepted, and there is never a distance surcharge.
What areas of Chester do you serve?
We serve patients from across Chester by telehealth, including downtown Chester and the greater Delaware County area of the Philadelphia metro.
How does compounded medication compare on cost for Chester patients?
Compounded semaglutide from $166/month and tirzepatide from $233/month are a fraction of typical brand-name cash prices. Chester patients see flat pricing up front, and compounded semaglutide and tirzepatide are not FDA-approved or brand-identical, which Dr. Sharma reviews with you.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Chester, Pennsylvania by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.